HIV NAT testing for plasma
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics COBAS AmpliScreen HIV-1 Test v1.5 gains FDA approval for screening source plasma and organ donations, announced March 2. Roche's submission was supported by Bayer Healthcare data, and Bayer will be able to perform in-house nucleic acid testing for HIV-1 in plasma donations using the Roche technology...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.